Roy Weiss

Title: Roy Weiss: Innovator in Treating Allan-Herndon-Dudley Syndrome

Introduction

Roy Weiss is a notable inventor based in Miami Beach, FL (US). He has made significant contributions to the field of medicine, particularly in the treatment of rare genetic disorders. His innovative approach has led to the development of a patent that addresses a critical health issue.

Latest Patents

Roy Weiss holds a patent for "Methods for treating Allan-Herndon-Dudley syndrome." This patent outlines methods that involve administering 3,5-diiodothyropropionic acid (DITPA) to individuals affected by the syndrome. The administration of DITPA is designed to reduce triiodothyronine ('T3') serum levels to normal, increase T3 brain levels to normal, and maintain normal serum levels of thyroxine (T4) and thyroid-stimulating hormone (TSH). This treatment can be applied to both children and adults, showcasing its versatility and importance.

Career Highlights

Throughout his career, Roy Weiss has worked with various organizations, including Prizm, LLC and the University of Miami. His work in these institutions has allowed him to collaborate with other experts in the field and further his research on thyroid-related disorders.

Collaborations

Roy Weiss has collaborated with notable professionals such as Samuel Refetoff and Khemraj Hirani. These partnerships have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Roy Weiss is a distinguished inventor whose work in treating Allan-Herndon-Dudley syndrome has the potential to improve the lives of many individuals. His innovative methods and collaborations highlight the importance of research in addressing complex health issues.